Literature DB >> 2470399

Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase.

A L DeVico1, T D Copeland, F D Veronese, S Oroszlan, R C Gallo, M G Sarngadharan.   

Abstract

We have raised a rabbit monospecific antibody against a synthetic peptide derived from a sequence within the COOH-terminal portion of the reverse transcriptase (RT) of HIV-1. This sequence was also found to be conserved in the predicted amino acid sequence of HIV-2. The antibody, designated C2003, cross-reacted with HIV-2 RT on immunoblots of HIV-2 virus extract and directly inhibited HIV-2 RT activity. Fractionation of HIV-2 RT by immunoaffinity chromatography with C2003 antibody yielded a pair of viral proteins of 68 and 55 kD associated with both RT and RNAse H activities. Both proteins were found to be highly immunogenic, recognized by 11 of 11 human sera that previously tested positive for antibodies to HIV-2 antigens in immunoblot assays.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470399     DOI: 10.1089/aid.1989.5.51

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.

Authors:  Z Sevilya; S Loya; N Adir; A Hizi
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

2.  Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription.

Authors:  Klara Post; Jianhui Guo; Kathryn J Howard; Michael D Powell; Jennifer T Miller; Amnon Hizi; Stuart F J Le Grice; Judith G Levin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.